Clinical Trial Update: A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating 2% lidocaine injection for male rigid cystoscopy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• 2% lidocaine injection (lidocaine)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Bladder Cancer | Phase 3 | Status: WITHDRAWN